Investigating the efficacy of an add-on acceptance and commitment inpatient therapy in gerontopsychiatric patients diagnosed with depression and chronic pain - a randomized controlled trial.

Not Applicable

Recruiting

• Conditions: Chronic pain; F32.2; F32.0; F33.0; Recurrent depressive disorder, current episode severe without psychotic symptoms; F32.1; Mild depressive episode; Severe depressive episode without psychotic symptoms; Recurrent depressive disorder, current episode mild; Recurrent depressive disorder, current episode moderate

• Registration Number: DRKS00032239
• Lead Sponsor: Christophsbad Akademie für Psychotherapie (C-AP), Klinikum Christophsbad, Forschungssektion für angewandte Psychotherapie und Psychiatrie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Depressive episode, currently mild, moderate or severe without psychotic symptoms
Recurrent depressive episode, currently mild, moderate or severe without psychotic symptoms
Fulfillment of the criteria of the questionnaire chronic pain
Fluent in written and spoken German

Exclusion Criteria

Reduction of intelligence according to clinical impression
Acute suicidality
Acute danger to others
Acute self-injury
Acute psychotic symptoms
Bipolar disorders (current or past episodes)
Schizophrenic disorders (current or past episodes)
Biological therapy methods: Electroconvulsive therapy (ECT) and esketamine treatment (Spravato).
Suspicion of a dementia and/or brain organic disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depressive symptoms (self-assessment) (BDI-II)<br>Depressive symptoms (Objective Rater) (GRID-HAMD)<br>Pain acceptance: (CPAQ-D)<br><br>3 measurement time points: T1 (baseline: 1 week before intervention), T2 (post measurement: 1 week after completion of intervention), T3 (follow-up measurement: 3 months after completion of intervention).

Secondary Outcome Measures

Name	Time	Method
Pain intensity (BPI)<br>Psychological flexibility (FAH-II)<br>Health-related quality of life (SF-12)<br><br>3 measurement time points: T1 (baseline: 1 week before intervention), T2 (post measurement: 1 week after completion of intervention), T3 (follow-up measurement: 3 months after completion of intervention).